World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
115
Citations
46215
World Ranking
194
National Ranking
89

Medicine

D-Index
115
Citations
46690
World Ranking
4566
National Ranking
2480

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 1995 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1981 - Member of the National Academy of Medicine (NAM)
  • 1972 - Fellow of John Simon Guggenheim Memorial Foundation
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Thomas C. Merigan is affiliated with Stanford University in the United States. Their work primarily spans the fields of Medicine and Immunology and Microbiology, with notable focus on Infectious Diseases and Virology. The scientist's research interests are closely tied to HIV/AIDS drug development and treatment, as well as broader HIV research and interventions.

Among the documented publications, Thomas C. Merigan is credited for the paper titled "Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection", published in 2020. This work was disseminated through the UNC Libraries publication venue.

Throughout their research career, they have collaborated with several co-authors, reflecting an interdisciplinary and cooperative approach. Frequent collaborators include:

  • Gregory K. Robbins
  • Victor De Gruttola
  • Robert W. Shafer
  • Laura Smeaton
  • Sally Snyder

Thomas C. Merigan's presence in academic venues is predominantly recorded in UNC Libraries, which serves as a platform for their published work.

The scientist's academic focus is also evident in the main topics they have extensively explored, such as:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions

Recognition for their contributions to science includes several awards and memberships in prestigious organizations. Thomas C. Merigan was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1995. They have been a Member of the National Academy of Medicine (NAM) since 1981 and a Fellow of the John Simon Guggenheim Memorial Foundation since 1972. Additionally, they are a Member of the Association of American Physicians.

Best Publications

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

    Ann C. Collier;Robert W. Coombs;David A. Schoenfeld;Roland L. Bassett

  • Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays

    Michael J. Kozal;Nila Shah;Naiping Shen;Robert Yang

  • The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

    M. A. Fischl;D. D. Richman;N. Hansen;A. C. Collier

  • Recombinant interferon-gamma increases HLA-DR synthesis and expression.

    T Y Basham;T C Merigan

  • Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis

    Harry B. Greenberg;Richard B. Pollard;Larry I. Lutwick;Peter B. Gregory

  • A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

    John D. Baxter;Douglas L. Mayers;Deborah N. Wentworth;James D. Neaton

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Jordan U. Gutterman;Seymour Fine;Jorge Quesada;Sandra J. Horning

  • A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

    Thomas C. Merigan;Dale G. Renlund;Susan Keay;Michael R. Bristow

  • Recombinant Gamma Interferon Induces HLA-DR Expression on Cultured Human Keratinocytes

    Teresa Y. Basham;Brian J. Nickoloff;Thomas C. Merigan;Vera B. Morhenn

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection

    Kahn Jo;Lagakos Sw;Richman Dd;Cross A

  • Human leukocyte Interferon for the treatment of herpes zoster in patients with cancer.

    Thomas C. Merigan;Kenneth H. Rand;Richard B. Pollard;Paul S. Abdallah

  • A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome

    Margaret A. Fischl;Corette B. Parker;Carla Pettinelli;Michael Wulfsohn

  • Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

    Hannah A. Valantine;Shao-Zhou Gao;Santosh G. Menon;Dale G. Renlund

  • Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    Ronald T. Mitsuyasu;Thomas C. Merigan;Andrew D Carr;Jerome A. Zack

  • The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients

    Jonathan M. Schapiro;Mark A. Winters;Fran Stewart;Bradley Efron

  • Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

    Thomas C. Merigan;Karol Sikora;James H. Breeden;Ronald Levy

Frequent Co-Authors

Mark A. Winters
Mark A. Winters Stanford University
David Katzenstein
David Katzenstein Stanford University
Robert W. Shafer
Robert W. Shafer Stanford University
Richard B. Pollard
Richard B. Pollard University of California, Davis
William S. Robinson
William S. Robinson Stanford University
Mark Holodniy
Mark Holodniy Stanford University
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Ann M. Arvin
Ann M. Arvin Stanford University
Douglas D. Richman
Douglas D. Richman University of California, San Diego
David A. Stevens
David A. Stevens Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond traditional microbiology, exploring related online degrees can open doors to diverse career pathways. One growing field is health information management, which combines healthcare knowledge with data analytics. Understanding the health information management job description and salary offers insight into opportunities that balance patient care with information science.

When considering education, it is important to choose a program with reputable accreditation. For example, the accredited online health information management degree cahiim programs ensure that students receive industry-recognized training, which enhances employability and expertise in the healthcare sector.

For those seeking quicker entry into healthcare administration, accelerated options like the accelerated medical billing and coding certificate online offer practical skills in managing medical records and billing systems. These certificates can complement a microbiology background by adding essential administrative competencies.

Finally, numerous medical programs online are available that allow students to tailor their education to specific interests within health and science. Combining microbiology with relevant online medical degrees can lead to versatile and rewarding career paths in healthcare, research, and technology.

Best Scientists Citing Thomas C. Merigan

Trending Scientists

Recently Published Articles